In mouse models of MPN, the LSD1 inhibitor IMG-7289 improved all aspects of disease, including mature cell counts, allele burden, cytokine levels, bone marrow fibrosis, and increased survival of mice. This evidence concerns the gene KDM1A and myeloproliferative neoplasm.